MEDTOX Scientific Inc. (MTOX) Reports In-Line Q4 EPS
MEDTOX Scientific Inc. (NASDAQ: MTOX) reported Q4 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $25 million versus the consensus estimate of $24.49 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix (NFLX) Director Jay Hoag Scoops Up 600,000 Shares
- CBL & Assoc. Properties (CBL) Tops Q2 FFO by 3c/Share; Guides FY16 FFO to Strong Side
- MobileIron (MOBL) Tops Q2 EPS by 1c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!